88 related articles for article (PubMed ID: 9520155)
21. Treatment of multidrug-resistant murine leukemia with antisense mdr1 oligodeoxynucleotides.
Hiratake S; Azuma E; Nishiguchi Y; Nagai M; Ido M; Komada Y; Sakurai M
Biomed Pharmacother; 1997; 51(6-7):276-83. PubMed ID: 9309248
[TBL] [Abstract][Full Text] [Related]
22. Expression of c-fos precedes MDR3 in vincristine and adriamycin selected multidrug resistant murine erythroleukemia cells.
Bhushan A; Slapak CA; Levy SB; Tritton TR
Biochem Biophys Res Commun; 1996 Sep; 226(3):819-21. PubMed ID: 8831695
[TBL] [Abstract][Full Text] [Related]
23. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides.
Liu C; Qureshi IA; Ding X; Shan Y; Huang Y; Xie Y; Ji M
Clin Sci (Lond); 1996 Jul; 91(1):93-8. PubMed ID: 8774266
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
[TBL] [Abstract][Full Text] [Related]
25. [Reversal of multidrug resistance of leukemia cell line in vitro by antisense phosphorothioate oligonucleotide].
Chen Y; Chen Z; Zhuo G; Hu J
Zhonghua Nei Ke Za Zhi; 1999 Jun; 38(6):373-6. PubMed ID: 11798669
[TBL] [Abstract][Full Text] [Related]
26. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.
Dantzig AH; Shepard RL; Law KL; Tabas L; Pratt S; Gillespie JS; Binkley SN; Kuhfeld MT; Starling JJ; Wrighton SA
J Pharmacol Exp Ther; 1999 Aug; 290(2):854-62. PubMed ID: 10411602
[TBL] [Abstract][Full Text] [Related]
27. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
Robey RW; Zhan Z; Piekarz RL; Kayastha GL; Fojo T; Bates SE
Clin Cancer Res; 2006 Mar; 12(5):1547-55. PubMed ID: 16533780
[TBL] [Abstract][Full Text] [Related]
28. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
Ernest S; Bello-Reuss E
Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
[TBL] [Abstract][Full Text] [Related]
29. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE
J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101
[TBL] [Abstract][Full Text] [Related]
30. Expression of ABC transporters in human hepatocyte carcinoma cells with cross-resistance to epirubicin and mitoxantrone.
Kamiyama N; Takagi S; Yamamoto C; Kudo T; Nakagawa T; Takahashi M; Nakanishi K; Takahashi H; Todo S; Iseki K
Anticancer Res; 2006; 26(2A):885-8. PubMed ID: 16619483
[TBL] [Abstract][Full Text] [Related]
31. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Chen GK; Durán GE; Mangili A; Beketic-Oreskovic L; Sikic BI
Br J Cancer; 2000 Oct; 83(7):892-8. PubMed ID: 10970691
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
33. Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.
Shepard RL; Cao J; Starling JJ; Dantzig AH
Int J Cancer; 2003 Jan; 103(1):121-5. PubMed ID: 12455064
[TBL] [Abstract][Full Text] [Related]
34. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
Dassow H; Lassner D; Remke H; Preiss R
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
[TBL] [Abstract][Full Text] [Related]
35. Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation.
Harvie RM; Davey MW; Davey RA
Int J Cancer; 1997 Sep; 73(1):164-7. PubMed ID: 9334825
[TBL] [Abstract][Full Text] [Related]
36. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
37. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
38. Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells.
Vanhoefer U; Voigt W; Hilger RA; Yin MB; Harstrick A; Seeber S; Rustum YM
Oncol Res; 1997; 9(9):485-94. PubMed ID: 9495454
[TBL] [Abstract][Full Text] [Related]
39. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
Kim R; Ohi Y; Inoue H; Aogi K; Toge T
Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
[TBL] [Abstract][Full Text] [Related]
40. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.
Allen JD; Brinkhuis RF; van Deemter L; Wijnholds J; Schinkel AH
Cancer Res; 2000 Oct; 60(20):5761-6. PubMed ID: 11059771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
